XIFIN Appoints John Kelly to Chief Information Officer

Former PatientKeeper and Cigna executive brings extensive technology leadership experience including customer-focused innovation and merging organizations for operational success SAN DIEGO–(BUSINESS WIRE)–XIFIN announced today that John Kelly has joined the company as chief information officer. In this role, a first for the company, Kelly will advance product and service cohesion and operations as XIFIN integrates … [Read more…]

Modivcare Announces Acquisition of Guardian Medical Monitoring

DENVER–(BUSINESS WIRE)–Modivcare Inc. (“Modivcare” or the “Company”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving patient outcomes, today announced the Company’s Remote Patient Monitoring (RPM) Segment has acquired Guardian Medical Monitoring, LLC (“GMM”) from its parent company, Guardian Alarm. Guardian Medical Monitoring is a … [Read more…]

Dr. Brandee Pappalardo Joins Fresenius Kabi as Chief Medical Officer for North America

LAKE ZURICH, Ill.–(BUSINESS WIRE)–#CMO–Fresenius Kabi announced today that Brandee Pappalardo, Ph.D., M.P.H. has joined the company as senior vice president and Chief Medical Officer for North America. Dr. Pappalardo reports to John Ducker, president and CEO of Fresenius Kabi in North America and is a member of the company’s North America executive committee. Fresenius Kabi … [Read more…]

Marinus Pharmaceuticals to Present at Upcoming Medical and Investor Conferences

RADNOR, Pa.–(BUSINESS WIRE)–$MRNS #MarinusPharma—Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that management will participate in the following investor and medical conferences in May and June: Citi Biotech Virtual Co-Panel Day May 18 at 3:30 p.m. ET. This presentation will be closed … [Read more…]

Propanc Biopharma Undertaking PRP Manufacturing & Development for Human Use

Novel Proenzyme Pharmaceutical Formulation to be Administered by Intravenous (I.V.) Injection in World First, Phase I First-In-Human Study in Advanced Cancer Patients MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that the Company is undertaking … [Read more…]

Article Reviews the Evolution of Arthroscopy from its Invention in 1912 to the Dawn of the Wireless ArthroFree™ Era

CLEVELAND–(BUSINESS WIRE)–#JOEI_TheJournal–A recent history of arthroscopy by Dr. James S. Williams, Jr., and Dr. Asheesh Gupta reports that while there have been numerous incremental advances in arthroscopic camera technology over the last half-century, the current systems remain largely unchanged. Surgeons are tethered to the surgical tower by a power cable and by a light cord … [Read more…]

Aldeyra Therapeutics Announces that Post-Hoc Analysis Using Computer Automated Grading of Phase 3 TRANQUILITY Trial Digital Photography Demonstrated Statistical Significance in Favor of Reproxalap Over Vehicle for Primary Endpoint of Ocular Redness

Post-Hoc Analysis Using Computer Automated Grading Indicated that Reproxalap is Statistically Superior to Vehicle (p=0.020) in Reducing Dry-Eye Associated Ocular Redness, the Primary Endpoint of Phase 3 TRANQUILITY Trial Statistical Superiority of Reproxalap over Vehicle (p=0.003) for the Primary Endpoint of Ocular Redness in the Previously Announced Phase 2 Dry Eye Chamber Trial Confirmed Using … [Read more…]

RenovoRx to Participate in Upcoming H.C Wainwright Global Investment Conference in May 2022

LOS ALTOS, Calif.–(BUSINESS WIRE)–RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announced management’s participation in the H.C. Wainwright Global Investment Conference on May 23-26, 2022 in Miami Beach, Florida. H.C. Wainwright Global Investment Conference Format and Dates: Hybrid, May 23-26, 2022 Location: Fountainebleau Miami Beach … [Read more…]

LifeWorks declares May 2022 cash dividend

TORONTO–(BUSINESS WIRE)–(TSX: LWRK) LifeWorks Inc. (the “Company” or “LifeWorks”) announced today a cash dividend of $0.065 per share for the month of May 2022, to be paid on June 15, 2022 to holders of record of shares of LWRK on May 31, 2022. LifeWorks designates this dividend to be an “eligible dividend” pursuant to subsection … [Read more…]

Anji Pharma Completes Patient Enrollment in Phase 2 Study of Pradigastat in Functional Constipation

CAMBRIDGE, Mass. & SHANGHAI–(BUSINESS WIRE)–Anji Pharma, an emerging global medicines company, today announced it has completed enrollment in its Phase 2 proof of concept study of pradigastat (ANJ908), a diacylglycerol acyltransferase 1 (DGAT1) inhibitor, in patients with functional constipation. The trial is being conducted in five clinical sites in the U.S. and 20 clinical sites … [Read more…]